IntoCell (287840.KQ) Stock Price
IntoCell Price
Revenue has compounded at 19.3% per year over the past 2 years to 2.30 B KRW. IntoCell's net margin stands at -461.2%, up from -1,037.8% several years earlier.
IntoCell stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
IntoCell business model & stock analysis
Frequently asked questions about IntoCell
Converted at the current exchange rate, the IntoCell share trades at 9.67 EUR (14,550.00 KRW).
The expected revenue of IntoCell is 10.42 B KRW. This figure is based on current financial data and reflects the company's business performance.
The expected profit of IntoCell is -5.18 B KRW. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of IntoCell is currently -42.17. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the IntoCell stock.
The price-to-sales ratio (P/S) of IntoCell is currently 20.95. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the IntoCell stock.
The Eulerpool Quality Score for IntoCell is 2/10.
The ISIN of IntoCell is KR7287840003. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of IntoCell is 287840.KQ. The ticker symbol is used to trade IntoCell shares on the stock exchange.
IntoCell stock
IntoCell Peer Group
All fundamentals and in-depth analysis of IntoCell
Our stock analysis for IntoCell stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of IntoCell. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.